Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

885 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
DOSAGE study: protocol for a phase III non-inferiority randomised trial investigating dose-reduced chemotherapy for advanced colorectal cancer in older patients.
Baltussen JC, van den Bos F, Slingerland M, Binda TRR, Liefers GJ, van den Hout WB, Fiocco M, Verschoor AJ, Cloos-van Balen M, Holterhues C, Houtsma D, Jochems A, Spierings LEAMM, van Bodegom-Vos L, Mooijaart SP, Gelderblom H, Speetjens FM, de Glas NA, Portielje JEA. Baltussen JC, et al. Among authors: gelderblom h. BMJ Open. 2024 Aug 13;14(8):e089882. doi: 10.1136/bmjopen-2024-089882. BMJ Open. 2024. PMID: 39142680 Free PMC article.
GSTP1 Ile105Val polymorphism correlates with progression-free survival in MCRC patients treated with or without irinotecan: a study of the Dutch Colorectal Cancer Group.
Kweekel DM, Koopman M, Antonini NF, Van der Straaten T, Nortier JW, Gelderblom H, Punt CJ, Guchelaar HJ. Kweekel DM, et al. Among authors: gelderblom h. Br J Cancer. 2008 Oct 21;99(8):1316-21. doi: 10.1038/sj.bjc.6604654. Epub 2008 Sep 16. Br J Cancer. 2008. PMID: 18797455 Free PMC article. Clinical Trial.
Pharmacogenetics in chemotherapy of colorectal cancer.
Henriette Tanja L, Guchelaar HJ, Gelderblom H. Henriette Tanja L, et al. Among authors: gelderblom h. Best Pract Res Clin Gastroenterol. 2009;23(2):257-73. doi: 10.1016/j.bpg.2009.02.011. Best Pract Res Clin Gastroenterol. 2009. PMID: 19414151 Review.
Pharmacogenetics in oncology: a promising field.
Houtsma D, Guchelaar HJ, Gelderblom H. Houtsma D, et al. Among authors: gelderblom h. Curr Pharm Des. 2010;16(2):155-63. doi: 10.2174/138161210790112719. Curr Pharm Des. 2010. PMID: 20205661 Review.
The fate of camptothecin glycoconjugate: report of a clinical hold during a phase II study of BAY 56-3722 (formerly BAY 38-3441), in patients with recurrent or metastatic colorectal cancer resistant/refractory to irinotecan.
Slingerland M, Gelderblom H. Slingerland M, et al. Among authors: gelderblom h. Invest New Drugs. 2012 Jun;30(3):1208-10. doi: 10.1007/s10637-011-9679-4. Epub 2011 May 6. Invest New Drugs. 2012. PMID: 21547368 Free PMC article. Clinical Trial.
Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand?
Anninga JK, Gelderblom H, Fiocco M, Kroep JR, Taminiau AH, Hogendoorn PC, Egeler RM. Anninga JK, et al. Among authors: gelderblom h. Eur J Cancer. 2011 Nov;47(16):2431-45. doi: 10.1016/j.ejca.2011.05.030. Epub 2011 Jun 22. Eur J Cancer. 2011. PMID: 21703851 Review.
Relationship between specific adverse events and efficacy of exemestane therapy in early postmenopausal breast cancer patients.
Fontein DBY, Houtsma D, Hille ETM, Seynaeve C, Putter H, Meershoek-Klein Kranenbarg E, Guchelaar HJ, Gelderblom H, Dirix LY, Paridaens R, Bartlett JMS, Nortier JWR, van de Velde CJH; Dutch TEAM Steering Committee. Fontein DBY, et al. Among authors: gelderblom h. Ann Oncol. 2012 Dec;23(12):3091-3097. doi: 10.1093/annonc/mds204. Epub 2012 Aug 2. Ann Oncol. 2012. PMID: 22865782 Free article.
Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: a phase I/II clinical trial.
Zeestraten EC, Speetjens FM, Welters MJ, Saadatmand S, Stynenbosch LF, Jongen R, Kapiteijn E, Gelderblom H, Nijman HW, Valentijn AR, Oostendorp J, Fathers LM, Drijfhout JW, van de Velde CJ, Kuppen PJ, van der Burg SH, Melief CJ. Zeestraten EC, et al. Among authors: gelderblom h. Int J Cancer. 2013 Apr 1;132(7):1581-91. doi: 10.1002/ijc.27819. Epub 2012 Nov 21. Int J Cancer. 2013. PMID: 22948952 Clinical Trial.
885 results